If you need a more accessible version of this website, click this button on the right. Switch to Accessible Site

WARNING

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close [x]

New Papers recently submitted for publication to peer review journals:

 Sponsel WE, Gray W, Groth SL, Stern AR, Walker JD. Paintball trauma and mechanisms of optic nerve injury: Rotational avulsion and rebound evulsion. Submitted to Invest Ophthalmol Vis Sci. August, 2011

Groth SL, Sponsel WE. Exploring the Alcon Humanitarian Services International Database. Submitted to J Cataract Refract Surg. Sept 2011

B.    Areas of Research Interest:

Glaucoma clinical and surgical research, ocular pharmacology, psychophysics, electrophysiology, circulatory physiology, scanning laser imaging studies, angiography, microcirculatory studies, visual function studies, genetics, ocular pharmacology and epidemiology, ocular trauma, surgical imaging, tube shunts, surgical technology.

 C.    Current Projects:

        1.    Clinical and FDA-approval studies with planned international release of new posterior tube shunt prosthetic implant (Sponsel Shunt) to be marketed by official licensor and co-patentee Mateen Ahmed and New World Medical of Rancho Cucamonga, CA.

        2.    Study of the relationship between preoperative gonioscopic status and the efficacy of mitomycin-C in nonpenetrating deep sclerectomy.

        3.    Study of the efficacy of the Craven-style conjunctival advancement flap in longstanding post-operative hypotony and bleb dysethesia.

       4.    Design of potential low-cost prosthetic iris implant options to increase the worldwide availability of surgical repair of traumatic and uveitic partial or total aniridia.

        5.   Study of the efficacy of needling revision of glaucoma filtering procedures with mitomycin C.

        6.    Study of the effects of fracture-induced phthalate release on the biocompatability of acrylic  intraocular lenses

        7.   Analysis of the Alcon Humanitarian Services International Database to assess worldwide patterns of cataract surgery evolution.

       8.     Contributing editor/author for DoD 10-year plan for Ophthalmic Research, Henry M. Jackson  Foundation for the Advancement of Military Medicine, Inc.; US Army Institute of Surgical Research

        9. Planning Committee for Bienniel Schepens Ocular Truama Symposium, Harvard University Medical School, Boston, MA, November, 2012

  

III.  RESEARCH

A.    Bibliography: (Attach sections in the following order with authors in sequence.)

1.     Books and/or chapters:

 1.     Gray W, Weiss CE, Sponsel WE. Computational and experimental study of paintball impact ocular trauma. Proc 24th International Symposium on Ballistics, New Orleans, LA, 23-27 Sep 2008. (Blass S and Walker J, eds; DEStech Publications, Lancaster, PA. 2008) 2:1260-67.

           2.     Gray W, Weiss CE, Bonvtch AR, Sponsel WE, Scribbick FW, Miller P, Armstrong AA, Walker JD, Nicolella DP. Modeling of paintball ocular trauma: A path towards development of an impact and blunt trauma predictive capability: SWRI Internal Research Report No. 18.R9664, 2008.

           3.     Sponsel WE, Trigo Y. Findings of The AAO/VFW Eye Screenings, 1998-2001. Proceedings of the XV International Perimetric Society Meeting (Wild J, ed; Kugler & Ghedini, 2002).

4.             Sponsel WE, Trigo Y. Oculokinetic Offset Acuity (OKAY) Testing and Early Detection of Pericentral Visual Field Defects. Proceedings of the XV International Perimetric Society Meeting (Wild J, ed; Kugler & Ghedini, 2002). 

4.    Sponsel WE.  Topical carbonic anhydrase inhibitors and visual function:  Association with retinal circulation and intraocular pressure in normal eyes.  Current Concepts  on Ocular Blood Flow in Glaucoma  (Kugler, Hague, 1999) pp. 251-265.

 4.     Sponsel WE.  Diagnosis and Clinical Tests in Glaucoma - Field and Other Visual Function Tests.  Oxford Textbook of Ophthalmology (Easty D, Spry P, eds;  Oxford University Press, Oxford, UK) 1998.

 5.     Sponsel WE, Shipman D. Effects of blood gases on ocular perfusion.  Vascular Risk Factors and Neuroprotection in Glaucoma - Update 1996. (Drance SM, ed; Kugler Publications bv, Amsterdam) 1997; pp 65-71.

 6.     Harrison JM, Elliott III WR, Kiel JW, Sponsel WE.  Effect of 10 Hz flicker on retinal hemodynamics measured by the Heidelberg retinal flowmeter.  Vision Science and Its Applications, Vol 1, 1997 OSA Technical Digest Series (Optical Society of America, Washington DC, 1997) pp 61-65.

 7.     Sponsel WE.  Effects of dorzolamide on blood flow and visual function.  Societas Ophthalmologica Europaea Proceedings 1997; 1531-1535.

 8.     Sponsel WE. Prevent Blindness America Visual Field Screening Study; Update.  Perimetry Update 1997; Proceedings of the XII International Perimetric Society Meeting (Mills RP and Heijl A, eds; Kugler & Ghedini 1996/1997) pp 459-465.

 9.     Quach TD, Nguyen BV, Elliott WR, Redmond RM, Sponsel WE.  Evaluating the delphi system for rapid assessment of visual function using the Humphrey Perimeter.  Perimetry Update 1997; Proceedings of the XII International Perimetric Society Meeting (Mills RP and Heijl A, eds; Kugler & Ghedini, 1996/1997) pp. 113-118.

 10.  Trigo Y, Sponsel WE, Elliott WR, Harrison JM, Kavanagh JT.  Comparing Humphrey visual fields and contrast sensitivity changes during CO2 supplementation and hyperventilation.  Proceedings of the XIIth International Perimetric Society Meeting, Perimetry Update 1996/1997; pp 1-3.

 11.  Harris A, Shoemaker JA, Weiland M, Pillunat LE, Sponsel WE. The acute effects of betaxolol on perimacular hemodynamics.  Update for glaucoma, ocular blood flow and drug treatment (Drance SM, ed; Kugler, Amsterdam) 1995; pp 109‑114.

 12.  Harris A, Wolf S, Arend O, Shoemaker J, Sponsel WE, Danis R, Martin B.  Exercise hastens retinal arteriovenous passage time.  Med Sci Sport & Exerc 1994;26:S162.

 13.  Sponsel WE.  Association of ocular circulation and visual function in glaucoma.  Chibret Int J Glaucoma 1994;10(3):29‑37.

 14.  Sponsel WE, Zetlan SR.  The Role of Psychophysiologic Tests in the Evaluation of the Glaucomatous Patient.  Management of Difficult Glaucoma:  A Clinician's Guide (Chapter 6). (Higginbotham, EJ and Lee, DA, eds; Blackwell Scientific Publications, Boston) 1993.

 15.  DePaul KL, Sponsel WE.  Multiple stimulus bowl perimetry using a four-button, quadrant‑related patient response system.  Perimetry Update 1990/91; Proceedings of the IX International Perimetric Society Meeting (Mills RP and Heijl A, eds; Kugler & Ghedini 1991) pp 413‑421.

 16.  Sponsel WE, Stodtmeister R, DePaul KL, Zetlan SR, Kaufman PL. Studies of the relationship between visual function and retinal blood flow in open angle glaucoma. Res Clin Forums 1989;11(2):69‑77.

17.  DePaul K, Sponsel WE, Kaufman PL.  The correlation of visual field and retinal blood flow asymmetry in glaucoma patients and ocular hypertensives. Non‑invasive Assessment of the Visual System, 1989 Technical Digest Series, Vol 7, (Optical Society of America, Washington D.C. 1989) pp 24‑27.

 18.  Redmond RM, Sponsel WE, Chandra A, Dallas NL.  Timolol versus placebo in presumed early glaucoma.  Res Clin Forums 1989; 11(2):79‑86.

 19.  Sponsel WE.  Timolol vs pilocarpine in open angle glaucoma: the observation of significant differences in visual field response in patients with clinically equivalent IOP control.  Chibret Int J Ophthalmol 1988; 5/3:50‑56.

 20.  Sponsel WE, Hobley A, Dallas NL, Henson DB, Chauhan B.  Visual field asymmetry in the detection of subclinical glaucoma simplex; a highly specific method for early diagnosis?  Acta XXV Int Congr Ophthalmol, Roma 1986, 1988 (Kugler Publications, Milano) 1645-1652.

 21.  Sponsel WE, Hobley A, Henson DB, Chauhan B, Dallas NL.  Quantitative supra-threshold static perimetry; the value of field score and asymmetry analysis in the early detection of chronic open angle glaucoma.  Doc Ophthalmol Proc Series 1987 (Greve EL, Heijl A, eds, Nijhoff/Junk) pp 217‑229.

 22.  Sponsel WE, Hobley A, Dallas NL, Henson DB.  Visual field survival; a comparison of the effects of pilocarpine and timolol in open‑angle glaucoma.  In: New Trends in Ophthalmology; Proceedings of the Glaucoma Society Meeting, Vol II/1, Turin 1986 (B Boles Carenini, ed: CIC, Roma) pp 168‑186.

 23.  Sponsel WE.  Visual Field Quantification in the Diagnosis and Assessment of Chronic Open Angle Glaucoma.  M.D. Thesis, Bristol University, Bristol U.K., 1985, pp 1-196.

 24.  Sponsel WE, Hobley AJ, Williams AH, Dallas NL, Henson DB.  Glaucoma assessment by microcomputer.  Proc VII Congr Eur Soc Ophthalmol (Helsinki Univ Press) 1985;570-571.

 25.  Dallas NL, Sponsel WE.  Quantification of visual fields in a longitudinal study of glaucoma patients; a simplified method of field analysis by microcomputer.  Res Clin Forums 1983;5(5):13-24.

 26.  Sponsel WE, Williams AH, Dallas NL, Henson DB.  A microcomputer-based glaucoma assessment system for clinical ophthalmologist.  Res Clin Forums 1983;5(5):25-35.

                2.     Papers published or in press: (Indicate initial and final page number; star {*} papers that are refereed.)

Sponsel WE, Groth SL. Mitomycin-augmented Nonpenetrating Deep Sclerectomy:Preoperative Gonioscopy and Postoperative Perimetric, Tonometric, and Medication Trends. Brit J Ophthalmol 2013; in press

 Singer M, Groth SL, Sponsel WE, Herro A, Pollard J, Cohen S, Cohen J. Association of OCT angle recess width with IOP response after intravitreal triamcinolone injection.  Retina 2012; in press.

 *1.       Ayliffe W, Groth SL, Sponsel WE. Small incision insertion of artificial iris prostheses. J        Cataract Refract Surg 2011; MS#JCRS-11-788R1.

 *2.                          Gray W, Sponsel WE, Scribbick FW, Stern AR, Weiss CE, Groth SL, Walker JD.

Numerical Modeling of Paintball Impact Ocular Trauma: Identification of Progressive Injury MechanismsInvest Ophthalmol Vis Sci. 2011 Aug 27. [Epub ahead of print] PMID: 21873664.

 *3.                          Gray W, Sponsel WE, Scribbick FW, Stern AR, Weiss CE, Groth SL, Walker JD.

Invest Ophthalmol Vis Sci. 2011 Aug 27. [Epub ahead of print]

 *4.                          Sponsel WE, Gray W, Scribbick FW, Stern AR, Weiss CE, Groth SL, Walker JD.

Invest Ophthalmol Vis Sci. 2011;52(8):5157-66.

 *5.                          Plange N, Arend KO, Kaup M, Doehmen B, Adams H, Hendricks S, Cordes A,

Huth J, Sponsel WE, Remky A.  Dronabinol and retinal hemodynamics in humans.Am J Ophthalmol. 2007;143(1):173-4.

 *6.                    Sponsel W, Chen N, Dang D, Paris G, Graybill J, Najvar LK, Zhou L, Lam KW,

Glickman R, Scribbick F. Topical voriconazole as a novel treatment for fungal keratitis. Antimicrob Agents Chemother. 2006;50(1):262-8.

 *7.                          Harrison JM, Glickman RD, Ballentine CS, Trigo Y, Pena MA, Kurian P, Najvar LK,

Kumar N, Patel AH, Sponsel WE, Graybill JR, Lloyd WC 3rd, Miller MM, Paris G,

Trujillo F, Miller A, Melendez R. Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.

Doc Ophthalmol. 2005;110(1):37-55.

 *8.          Remky A, Weber A, Arend O, Sponsel WE. Topical dorzolamide increases pericentral visual function in age-related maculopathy: pilot study findings with short-wavelength automated perimetry. Acta Ophthalmol Scand. 2005;83(2):154-60.

 *9.       Paris G, Zhao M, Sponsel WE.  Operative revision of nonfunctioning filtering blebs with 5-fluorouracil to regain IOP control.  Clin Exp Ophthalmol 2004;32:378-82.

 *10.      Sponsel WE.  Sustained perimacular vascular and visual response to topical beta-blockers in normal human eyes.  Brain Res Bull 2004;62:529-535.

 *11.      Schmeisser ET, Harrison JM, Sutter EE, Kiel J, Elliott WR, Sponsel WE.  Modification of the Heidelberg retinal flowmeter to record pattern and flicker induced blood flow changes.  Doc Ophthalmol 2003;106:257-263.

 *12.      Sponsel WE, Paris G, Trigo Y, Pena M.  Comparative Effects of Latanoprost  (XalatanTM) versus Unoprostone (Rescula) in Open-angle Glaucoma.  Am J Ophthalmol 2002;134(4):552-559.

*13.  Zhou L, Glickman RD, Chen N, Sponsel WE, Graybill JR, Lam K-W. Determination of Voriconazole in aqueous humor by liquid chromatography-electrospray ionization mass spectrometry.  J Chromatography 2002;776(2):213-220. (experimental laboratory study; new methodology)

*14.    Sponsel WE, Graybill JR, Nevarez HL, Dang D.  Ocular and Systemic

              Posaconazole (SCH-56592) Treatment of Invasive Fusarium solani Keratitis and

 Endophthalmitis.  Br J Ophthalmol. 86(7):829-30, 2002.  (clinical case study)

*15.    Sponsel WE, Paris GM, Trigo YT, Pena M, Weber A, Sanford DK, McKinnon

SJ. Latanoprost and brimonidine: Therapeutic and physiologic assessment before and after oral anti-inflammatory therapy.  Am J Ophthalmol 2002;133(1):11-18. (randomized clinical trial)

*16.      Allen CS, Sponsel WE, Trigo Y, Dirks M, Flynn W.  Comparison of the Frequency Doubling Technology screening algorithm and the Humphrey 24-2 SITA-fast in a large eye screening.  Clin Exp Ophthalmol 2002;30(1):8-14.  (cross-sectional population study)

*17.     Sponsel WE, Shoemaker J, Trigo Y, Mensah J, Rugwani R, Garrett B.  Frequency of sustained glaucomatous-type visual field loss and associated optic nerve cupping in Beaver Dam, Wisconsin.  Clin Exp Ophthalmol 2001;29(6):352-358.   (epidemiologic /prospective cohort study)

*18.      Paris G, Sponsel WE, Sandoval SS, Elliott WR, Trigo Y, Sanford DK, Harrison JM.  Sildenafil increases ocular perfusion.  Int Ophthalmol 2001;23(4-6):355-358.

*19.      Lehman DM, Sponsel WE, Stratton RF, Mensah J, Macdonald JC, Johnson-Pais TL, Coon H, Reveles XT, Cody JD, Leach RJ.  Genetic mapping of a novel X-linked recessive colobomatous microphthalmia.  Am J Med Genet 2001;101(2):114-119. (observational case series; genetic analysis)

*20.      Sponsel WE, Mensah J, Kiel JW, Remky A, Trigo Y, Baca W, Friberg T. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye. Am J Ophthalmol 2000;130(2):151-159.  (randomized clinical trial)

*21.      Sponsel WE, Terry S, Khuu HD, Lam KW, Frenzel H.  Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy.  Surv Ophthalmol 1999;43[Suppl]: S210-S213. (nonrandomized clinical trial)

*22.      Sponsel WE, Trigo Y, Hendricks J, Lloyd C.  Frequency Doubling Perimetry.  Am J Ophthalmol 1998;126(1):155-156.  (cross-sectional study)

*23.      Sponsel WE, Arango S, Trigo Y, Mensah J.  Clinical classification of glaucomatous visual field loss by frequency doubling perimetry.  Am J Ophthalmol 1998;125(6):830-836.  (cross-sectional study)

*24.      Sponsel WE, Harrison J, Elliott WR, Trigo Y, Kavanagh J, Harris A.  Dorzolamide hydrochloride and visual function in normal eyes.  Am J Ophthalmol 1997;123:759-766.  (randomized clinical trial)

*25.      Gerber SL, Cantor LB, Sponsel WE.  A comparison of post‑operative complications utilizing the dual chamber double plate Molteno implant versus the standard double plate Molteno with suture ligation.  Ophthalmic Surgery and Lasers 1997;28:905-10.  (randomized clinical trial)

*26.      Sponsel WE, Kaufman PL, Blum FG Jr.  Association of retinal capillary perfusion with visual status during chronic glaucoma therapy.  Ophthalmology 1997;104:1026-1032.  (nonrandomized clinical trial)

*27.      Sponsel WE, Zetlan SR, Stodtmeister R, Kaufman P.  Retinal capillary hemodynamics and VEP/pressure tolerance: evidence of retinal microcirculatory compromise in treated glaucomatous eyes.  Ophthalmologica 1997;211:172-177.  (randomized clinical trial)

*28.      Harris A, Joos K, Kay M, Evans D, Shetty R, Sponsel WE, Martin B.  Acute IOP elevation with scleral suction: effects on retrobulbar hemodynamics.  Brit J Ophthalmol 1996;80:1055‑1059.  (randomized clinical trial)

*29.      Sponsel WE, Tu E, Lee B. Prevent Blindness America Visual Field Screening Study.  Am J Ophthalmol 1996;121:735.  (observational case report)

*30.      Sponsel WE, Ritch R, Stamper R, Higginbotham EJ, Anderson DR, Wilson MR, Zimmerman TJ, and the Prevent Blindness America Glaucoma Advisory Committee.  Prevent Blindness America Visual Field Screening Study.  Am J Ophthalmol 1995;120:699‑708.  (population screening study)

*31.      Arend O, Harris A, Sponsel WE, Remky A, Reim M, Wolf S.  Macular capillary particle velocitites: a blue field and scanning laser comparison.  Graefe's Archive 1995;233:244‑249. (nonrandomized clinical trial)

*32.      Cantor LB, Harris A, Wolf S, Sponsel WE, Arend, O.  Measurement of superficial optic nerve head capillary blood velocities by scanning laser fluorescein angiography.  J Glaucoma (Suppl) 1994;3:s61‑64.  (cohort study; new methodology)

*33.      Prager TC, Fea AM, Sponsel WE, Schweitzer FC, McNulty L, Garcia CA.  The gold foil electrode in pattern electroretinography.  Documenta Ophthalmologica 1994;86:267‑274.  (clinical trial)

*34.      Arend O, Wolf S, Remky A, Sponsel WE, Harris A, Bertram B, Reim M.  Perifoveal microcirculation with non‑insulin dependent diabetes mellitus.  Graefe's Archive 1994;232:225‑231.  (nonrandomized clinical trial)

*35.      Menage MJ, Robinson JC, Kaufman PL, Sponsel WE.  Retinal blood flow after superior cervical ganglionectomy: A laser doppler study in the cynomolgus monkey.  Br J Ophthalmol 1994;78:49‑53.  (laboratory study)

*36.      Harris A, Arend O, Kopecky K, Caldemeyer K, Wolf S, Sponsel WE, Martin B. Physiological perturbation of ocular and cerebral blood flow as measured by scanning laser ophthalmoscopy and color Doppler imaging.  Surv Ophthalmol 1994;(Suppl, May):S81‑S86. (controlled clinical trial)

*37.      Wolf S, Arend O, Sponsel WE, Schulte K, Cantor LB, Reim M.  Retinal hemodynamics using scanning laser ophthalmoscopy and hemorheology in chronic open angle glaucoma. Ophthalmology 1993;100:1561‑1566.  (controlled clinical trial)

*38.      Sponsel WE.  Quantification and monitoring of visual field defects and prospective, randomized comparison of pilocarpine and timolol using computerized perimetry.  J Glaucoma 1993;2 (suppl A):S15‑S19.  (clinical study analysis)

*39.      Klein BEK, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ.  Prevalence of Glaucoma; The Beaver Dam Eye Study.  Ophthalmology 1992;99:1499‑1504.  (large-scale epidemiologic population study)

*40.      Sponsel WE, Rapoza PA.  Posterior subcapsular cataracts associated with Indapamide therapy.  Arch Ophthalmol 1992;110:454.  (observational case report)

*41.      Zetlan SR, Sponsel WE, Stodtmeister R.  Retinal capillary hemodynamics, visual‑evoked potentials, and pressure tolerance in normal human eyes.  Invest Ophthalmol Vis Sci 1992;33:1857‑1863.  (randomized clinical trial)

*42.      Sponsel WE, DePaul KL, Zetlan SR.  Retinal hemodynamic effects of carbon dioxide, hyperoxia and mild hypoxia.  Invest Ophthalmol Vis Sci 1992;33:1864‑1869.  (randomized clinical trial)

*43.      Barondes MJ, Sponsel WE, Stevens TS, Plotnik RD.  Tuberculous Choroiditis diagnosed by Chorioretinal Endobiopsy.  Am J Ophthalmol 1991;112:460‑461.  (interventional case report; new methodology)

*44.      Wallow IHL, Sponsel WE, Stevens TS.  Clinicopathologic correlation of diode laser burns in monkey.  Arch Ophthalmol 1991;109:648‑653.  (experimental laboratory study)

*45.      Sponsel WE, DePaul KL, Martone JF, Shields MB, Ollie AR, Stewart WC.  Association of Vistech contrast sensitivity and visual field findings in glaucoma.  Brit J Ophthalmol 1991;75:558‑560 (cross-sectional study).

*46.      Sponsel WE, DePaul KL, Kaufman PL.  Correlation of visual function and retinal leukocyte velocity in glaucoma.  Am J Ophthalmol 1990;109:49‑54.  (nonrandomized clinical trial)

*47.      Sponsel WE, Kaufman PL, Strinden TI, DePaul KL, Bowes HN, Olander KW, Barnebey HS. Evaluation of the Keeler Pulsair non‑contact tonometer.  Acta Ophthalmologica 1989;67:567‑572.  (experimental laboratory study)

           

*48.      Sponsel WE.  Quantification and monitoring of visual field defects and a prospective, randomized comparison of pilocarpine and timolol using computerized perimetry.  Surv Ophthalmol (Suppl) 1989;33:427‑428.  (randomized clinical trial)

*49.      Dallas NL, Sponsel WE, Hobley AJ.  Comparative evaluation of Timolol,             Maleate and Pilocarpine in the treatment of open angle glaucoma.  Eye 1988;2:243‑249.  (randomized clinical trial)

*50.      Henson DB, Hobley AJ, Chauhan B, Sponsel WE, Dallas NL.  The importance of visual field score and asymmetry in the detection of glaucoma.  Am J Optom Phys Optics 1986;63:714‑723.  (cross-sectional study)

*51.      Sponsel WE, Hobley AJ, Williams AH, Dallas NL.  Glaucoma assessment by microcomputer. Trans Ophthalmol Soc UK 1984;104:100‑105 (case-control study; new methodology).

*52.      Sponsel WE.  Simple and effective breast pump for nursing mothers.  Br Med J 1983;286:1180‑1181 (interventional case report; new methodology).

*53.      Sponsel WE, Dallas NL, Burbridge L.  Visual field survival: the response to timolol therapy in open‑angle glaucoma.  Br J Ophthalmol 1983;67:220‑227.  (case-control study)

*54.      Campbell WB, Cooper MJ, Sponsel WE, Baird RN, Peacock JH.  Transaxillary sympathectomy ‑ is a one‑stage bilateral procedure safe?  Br J Surg 1982;69:s29‑31.  (case-control study)

                     4.        Association for Research in Vision and Ophthalmology IOVS Abstracts/Presentations:

◦                              

            1.   Salman Porbandarwalla, Kelly Green, Randolph Glickman, William Sponsel, John Denny, and Neeru Kumar. Phthalates Released From IOLs Affect Protein Expression In Corneal Epithelial Cells 
ARVO Meeting Abstracts April 22, 2011 52:281



             

            2.  Sylvia L. Groth and William E. Sponsel. Effectiveness Of Needling Revision With Mitomycin C For Failing Blebs In A Largely Hispanic Population 
ARVO Meeting Abstracts April 22, 2011 52:648

            3.  W. E. Sponsel and W. Ayliffe. A Comparision of Traditional and Novel Iris Implant Surgery Methods and New Technique for Insertion of Artificial Irides. ARVO Meeting Abstracts April 11, 2010 51:3119

             

            4.  W. E. Sponsel, W. Gray, J. D. Walker, D. P. Nicolella, F. W. Scribbick, C. E. Weiss, and P. Miller. Histopathologic Blunt Ocular Trauma Impact Thresholds ARVO Meeting Abstracts April 11, 2009 50:4900W.

             

            5.  Gray W and W. E. Sponsel. Lens Displacement Mechanism in Dynamic Blunt Trauma Events 
ARVO Meeting Abstracts April 11, 2008 49:2778



                                 

                                           6.  W. E. Sponsel, W. Gray, A. Bonivtch, D. Nicolella, J. Walker, and F. Scribbick.

                 Paintball Trauma: Empirical and Mathematical Models to Assess Blunt Periocular Injury Reveal Likely Mechanism for Optic Nerve Traction/Avulsion 
ARVO Meeting Abstracts April 11, 2008 49:5257

             

            7.   W. E. Sponsel, W. Gray, A. Bonivtch, C. E. Weiss, F. W. Scribbick, J. D. Walker, and D. P. Nicolella.  Investigation of Paintball Ocular Trauma: A Path Towards Safer Paintballs 
ARVO Meeting Abstracts May 10, 2007 48:5485

8.     H. Koenig, Y. Trigo, and W. E. Sponsel.  Who Attends Free Eye Screenings? 
ARVO Meeting Abstracts May 10, 2007 48:2407


9.     S. H. Hahn, G. Lindhorst, S. Ferlitto, Y. Trigo, H. Koenig, and W. E. Sponsel

Project Vision SOS (Saving Our Sight): Post-Screening Follow-Up Analysis 
ARVO Meeting Abstracts May 10, 2007 48:2408


10.  Y. Trigo, H. Koenig, and W. E. Sponsel. Association of Diabetes and Glaucoma in a Predominantly Hispanic Screening Population 
ARVO Meeting Abstracts May 10, 2007 48:4340





11.  L. Nguyen, W.E. Sponsel, G. Lindhorst, M. Sinai, Y. Trigo, and J. Hendricks

Establishing Appropriate Asymmetry Cut-off Criteria for Population Screening Using a New HRT III Algorithm in a Predominately Mexican American Population 
ARVO Meeting Abstracts May 1, 2006 47:3644





12.  G. Lindhorst, W.E. Sponsel, M. Sinai, and Y. Trigo. Asymmetry Analysis Using the Heidelberg Retina Tomograph Scanning Laser in a Predominantly Mexican-American Clinical Population 
ARVO Meeting Abstracts May 1, 2006 47:3406


13.  Y. Trigo, J. Hendricks, H. Koenig, and W.E. Sponsel. Clinical Follow-Up Return Rates Among Those Screening Postively for Sight-Threatening Disease in Bexar County, Texas ARVO Meeting Abstracts May 1, 2006 47:3439





14.  W.E. Sponsel, C. Hennessey, C. McCash, G. Lindhorst, and B. Moomaw

                        Automated Detection of Accommodative-Convergence-Miosis Dysfunction in Children 
                                      ARVO Meeting Abstracts May 1, 2006 47:706

15.  M.K. Green, S. Porbandarwalla, N. Kumar, V.L. Dougherty, C.P. Mullens,

                R.D. GlickmanS.B.H. Bach, and W.E. Sponsel. Can Phthlates Be Released From

                Intraocular Lenses? 
ARVO Meeting Abstracts May 1, 2006 47:608.

16.  Jones R, Sponsel WE, Stodtmeister R.  Central Retinal Vein Collapse Pressure in

Glaucoma Suspects with Cup-to-Disc Asymmetry.   Invest Ophthalmol Vis Sci 2005;46:E-abstract 1337.

17.  Trigo Y, Hendricks J, Sponsel W.  Systematic Detection and Characterization of Glaucoma at Multiple Sites in Bexar County, Texas.  Invest Ophthalmol Vis Sci 2005;46:E-abstract 3652.

18.     Sponsel RE, Glickman R, Graybill J, Paris G, Trujillo F, Harrison J, Trigo Y, Najvar L, Woodward L.  Comparisons of the Ocular Penetration of Topical and Intravenous Voriconazole and Amphotericin B in Fungal Endophthalmitis.  Invest Ophthalmol Vis Sci 2005;46:E-abstract 2779.

19 .    Green MK, Sponsel WE, Paris G, Vogel R, Kavanagh J, Arango S, Baca W, Parvez S.   Reversal of Progressive Visual Field Loss in Eyes with Pericentral Scotoma With and Without Macular Degeneration.  Invest Ophthalmol Vis Sci 2004;45: E-abstract 5581.

20.     Trigo Y, Sponsel WE, Paris G, McKinnon SJ, Pena MA.  AAO/VFW Cumulative Results 1998-2003:  Frequency Doubling Technology vs. Humphrey Visual Field and Optic Disc Pathology.  Invest Ophthalmol Vis Sci 2004;45: E-abstract 4491.

21.     Paris G, Trujillo F, Woodward L, Trigo Y, Ballentine CS, Najvar LK, Glickman RD, Harrison JM, Graybill J, Sponsel WE.  Micafungin vs. Amphothericin B in the Treatment of Experimental Aspergillosis Endophthalmitis.  Invest Ophthalmol Vis Sci 2004;45: E-abstract 4014.

22.     Sponsel WE, Trujillo F, Paris G, Woodward L, Graybill J, Trigo Y, Glickman RD, Najvar L, Harrison JM.  Voriconazole vs Amphotericin B in the Treatment of Fungal Endophthalmitis.  Invest Ophthalmol Vis Sci 2004;45: E-abstract 516.

23.     Trujillo F, Paris G, Woodward L, Graybill J, Pena M, Najvar L, Trigo Y, Sponsel WE.  Comparison of Two Antifungal Agents, Natamycin and Micafungin, for Fungal Keratitis.  Invest Ophthalmol Vis Sci 2004;45: E-abstract 113.

24.     Harrison JM, Ballentine CS, Trigo Y, Pena MA, Kurian P, Paris GR, Trujillo F, Melendez RF, Miller AM, Sponsel WE.  Retinal Function of Rabbits Assessed by ERG Before and After Induction of Ocular Aspergillosis and Treatment by the Antimicrobials, Micafungin and Amphotericin B.  Invest Ophthalmol Vis Sci 2004;45: E-abstract 510.

25.     Dang DT, Glickman RD, Graybill JR, Sponsel WE, Miller A, Melendez R, Pena M, Trigo Y, Reitsamer HA.  Potentiation of Topical Voriconazole (VCZ) Ocular Penetration by Pretreatment with Topical Latanoprost (LT).  Invest Ophthalmol Vis Sci 2003;44: #4275.

26.     Lindhorst GC, Sponsel WE, McKinnon SJ, Trigo Y, Pena P.  Comparative Analysis of Scanning Laser Topographic Indices Relative to Humphrey Visual Field and Simultaneous Stereo Disc Analysis. Invest Ophthalmol Vis Sci 2003;44: #3393.

27.     Miller AM, Liu Y, Sponsel WE.  Non-Penetrating Deep Sclerectomy with Mitomycin C and Trabeculectomy with Mitomycin C:  A Comparison of Efficacy and Complications.  Invest Ophthalmol Vis Sci 2003;44: #3310.

28.     Dang DT, Sponsel WE, Graybill J, Nevares H.  Combined Topical and Systemic Posaconazole (SCH-5692) for Treatment of Refractory Fusarium Keratitis and Endophthalmitis.  Invest Ophthalmol Vis Sci 2002;43: #882.

29.     Sponsel WE, Fraiser KJ, Mayo GL, Bui C, Simms J.  Oculokinetic Offset Acuity (OKAy) Testing and Early Detection of Pericentral Visual Field Defects.  Invest Ophthalmol Vis Sci 2002;43: #2155.

30.     Madsen B, Sponsel WE, McKinnon SJ.  Evaluation of VisionRx Computer Based Perimetry vs. Humprey Visual Field.  Invest Ophthalmol Vis Sci 2002;43: #2174.

31.     Trigo Y, Pena M, Paris G, Sponsel WE.  AAO/VFW Eye Screening 2001:  Diagnostic Power of First-pass Intraocular Pressure Measurement versus First-pass Frequency Doubling Technology.  Invest Ophthalmol Vis Sci 2002;43: #3325.

                             

32.      Friedman M, Applegate R, Sponsel WE, McKinnon SJ, Gross H, Trigo Y, Pena M. Effects

           of Sildenafil Citrate on Optical Properties of the Eye. Invest Ophthalmol Vis Sci 2002;43:

           #3250.

33.     Paris G, Sponsel WE, Trigo Y, Pena M.  Comparative Effects of Latanoprost and Unoprostone on IOP, Visual Function, and POBF in Open Angle Glaucoma.  Invest Ophthalmol Vis Sci 2002;43: #4114. 

34.     Dang D, Chen N, Graybill J, Paris G, Trigo Y, Pena M, Glickman R, Lam K-W, Sponsel WE. Evaluation of topical voriconazole as a novel treatment for fungal keratitis. Invest Ophthalmol Vis Sci (Suppl) 2001;42(4):S740.  Abstract 3965.

35.     Trigo Y, Paris G, Sponsel WE.  AAO/VFW Eye Screenings 1998-2000; Cumulative and comparative visual field, neural imaging, circulatory and tonometric findings. Invest Ophthalmol Vis Sci (Suppl) 2001;42(4):S557.  Abstract 2988.

36.     Bernal V, Paris G, Dang D, Trigo Y, Pena M, Glickman R, Graybill J, Sponsel WE. Possible potentiation of antimicrobial drug m=penetration by topical latanoprost coadministration. Invest Ophthalmol Vis Sci (Suppl) 2001;42(4):S174.  Abstract 934.

37.     Paris G, Trigo Y, Pena M, Sanford D, Weber A, Sponsel WE. Pulsatile ocular blood flow responses to latanoprost or brimonidine alone and in combination with oral indomethacin. Invest Ophthalmol Vis Sci (Suppl) 2001;42(4):S486.  Abstract 475.

38.     Trigo Y, Sponsel WE, Sandoval SS, Paris G, Vendal M, Crowhurst C, Allen C.  Comparing intraocular pressures among those failing frequency doubling technology at the 1998 versus the 1999 AAO/VFW eye screenings. Invest Ophthalmol Vis Sci (Suppl) 2000;41(4):S477.  Abstract 2538.

39.     Paris G, Trigo Y, Sponsel WE, McKinnon S, Sanford S, Sandoval S, Dawson T, Howitt J.     DisCam stereo disc analysis and Humphrey visual field findings among those failing FDT

at the 1998 and 1999 AAO/VFW Eye Screenings. Invest Ophthalmol Vis Sci (Suppl)  2000;41(4):S285.  Abstract 1503.

40.     Sponsel WE, Sandoval S, Chen N, Kavanagh J, Khemsara V, Sharma S, Singh G, Paris G, Sanford K, McKinnon S.  Effects of sildenafil (Viagra) on ocular perfusion and contrast sensitivity.  Invest Ophthalmol Vis Sci (Suppl) 2000;41(4):S98.  Abstract 515.

41.     Lehman DM, Sponsel WE, Stratton RF, MacDonald JC, Coon H, Reveles XT, Leach RJ.  A genetic and clinical evaluation of a novel X-linked colobomatous microphthalmia. Invest Ophthalmol Vis Sci (Suppl) 2000;41(4):S7.  Abstract 35.

42.     Allen CS, Sponsel WE, Trigo Y, Dirks MS, Flynn WJ.  Evaluation of frequency doubling perimeter screening algorithm in a large glaucoma screening.  Invest Ophthalmol Vis Sci (Suppl) 1999;40(4):S843.  Abstract 4438.

43.     Kavanagh JT, Sponsel WE, Trigo Y, Allen CS.  Comparing the morphologic characteristics of the optic nerve as determined by the GDX in eyes with demonstrated glaucomatous visual field defects as measured by the Humphrey visual field analyzer.  Invest Ophthalmol Vis Sci (Suppl) 1999;40(4):S839.  Abstract 4418.

44.     Mensah JM, Trigo Y, Sponsel WE.  Short-term differences in pulse amplitude and pulsatile ocular blood flow with latanoprost and timolol.  Invest Ophthalmol Vis Sci (Suppl) 1999;40(4):S492.  Abstract 2597.

45.     Trigo Y, Sponsel WE.  Intraocular pressures among those failing frequency doubling technology at the 1998 AAO sponsored VFW convention national eye screening.  Invest Ophthalmol Vis Sci (Suppl) 1999;40(4):S282.  Abstract 1492.

46.     Rugwani R, Tu EY, Sponsel WE.  Effect of corneal thickness on the correlation of manometric and applanation pressure measurements in eye bank whole globes.  Invest Ophthalmol Vis Sci (Suppl) 1998;39:937.

47.     Trigo Y, Sponsel WE, Mensah JM, Royall R, Polk M, Remky A.  Frequency doubling perimetry in screening patients with early Alzheimer’s disease.  Invest Ophthalmol Vis Sci (Suppl) 1998;39:556.

48.     In K, Mensah JM, Leach R, Lehman D, Harrison JM, Sponsel WE.  A genetic and clinical evaluation of familial glaucoma.  Invest Ophthalmol Vis Sci (Suppl) 1998;39:514.

49.     Mensah JM, Baca W, Trigo Y, Quach TD, Friberg T, Remky A, Sponsel WE.  A double-masked, crossover, placebo controlled, single center pilot study comparing the effects of latanoprost versus timolol XE on intraocular pressure in the normal eye.  Invest Ophthalmol Vis Sci (Suppl) 1998;39:257.

50.     Sponsel WE, Trigo Y, Remky A, Mensah JM, Baca W, Kavanagh J.  Discam:  A clinically practical, reproducible and rapid means for obtaining and comparing glaucomatous stereo disc images. Invest Ophthalmol Vis Sci (Suppl) 1998;39:28.

51.     Dudenhoefer EJ, Nesteruk LI, Ohara MA, Sponsel WE.  Correlation of color campimetry and Humphrey field analysis in glaucoma patients.  Invest Ophthalmol Vis Sci (Suppl) 1998;39:24.

52.     Quach TD, Lee K, Trigo Y, Mensah J, Rugwani R, Klein BEK, Klein R, Sponsel WE.  Beaver Dam Eye Study visual field follow-up (1988-95):  the preponderance of normal intraocular pressure among eyes with optic disc cupping and visual field loss.  Invest Ophthalmol Vis Sci (Suppl) 1998;39:13.

53.     Mensah JM, Lowry LC, Kavanagh JT, Sponsel WE, Harrison JE.  The chevron ratio; A new method of analysing the optic disc from stereo color photographs using vascular landmarks. Invest Ophthalmol Vis Sci (Suppl) 1997;38:831.

54.     Sponsel WE, Trigo Y, Elliott WR.  Dorzolamide affects the relationship between retinal microcirculation and visual function:  HRF findings.  Invest Ophthalmol Vis Sci (Suppl) 1997;38:439.

55.     Elliott WR, Shipman DL, Kavanagh JT, Sponsel WE, Ness J.  Scanning laser measurements in dorzolamide and placebo treated eyes:  Arteriovenous passage times in large and small retinal vessels during hyper- and hypocapnia.  Invest Ophthalmol Vis Sci (Suppl) 1997;38:777.

56.     Arango S, Trigo Y, Sponsel WE.  Assessment of glaucomatous visual loss by frequency doubling perimetry against Humphrey 30-2 reference standards.  Invest Ophthalmol Vis Sci (Suppl) 1997;38:567.

57.     Nguyen T, Arango S, Sponsel WE.  Effectiveness of needling revision with 5-FU in patients with failed filtering procedures.  Invest Ophthalmol Vis Sci (Suppl) 1997;38:1061.

58.     Trigo Y, Sponsel WE, Harrison JM, Elliott WR.  The effects of dorzolamide on visual function during CO2 supplementation and hyperventilation.  Invest Ophthalmol Vis Sci (Suppl) 1997;38:568.

59.     Kavanagh JT, Elliott WR, Sponsel WE.  Dorzolamide 2% has a protective effect on the perimacular circulation (as measured by indirect measures) during hyperventilation induced hypocapnia.  Invest Ophthalmol Vis Sci  (Suppl) 1997;38:777.

60.     Khuu HD, Lam KW, Sponsel WE.  Transconjunctival diffusion of timolol and betaxolol.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:1101.

61.     van Heuven WAJ, Kiel JW, Elliott WR, Harrison JM, Sponsel WE.  Evaluation of the Heidelberg retinal flowmeter.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:967.

62.     Lo MW, Lam KW, Sponsel WE.  Mitomycin C penetration into human sclera.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:833.

63.     Trigo Y, Sponsel WE, Elliott WR, Harrison JM.  Comparison of Humphrey visual field and contrast sensitivity changes during CO2 supplementation and hyperventilation.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:508.

64.     Quach TD, Nguyen BV, Sponsel WE.  Evaluation of Delphi system for rapid assessment of visual function using Humphrey perimeter.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:508.

65.     Kuffel R, Kavanagh JT, Sponsel WE.  Association of altitudinal glaucomatous visual field defects with systemic hypertensive status.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:507.

66.     Kavanagh JT, Ysasaga E, Sponsel WE.  Does dorzolamide 2% protect against hyperventilation-induced depression of perimacular circulation?  Invest Ophthalmol Vis Sci (Suppl) 1996;37:269.

67.     Elliott WR, Sponsel WE, Trigo Y, Harrison JM.  Retinal circulation changes during hyperventilation.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:268.

68.     Harrison JM, Elliott WR, Kiel JW, Sponsel WE.  Effect of 10 Hz flicker on retinal hemodynamics measured by the Heidelberg retinal flowmeter (HRF).  Invest Ophthalmol Vis Sci (Suppl) 1996;37:265.

69.     Sipman DL, Kavanagh JT, Elliott WR, Sponsel WE.  Scanning laser angiography reveals inverse filling responses in large and small retinal venules after CO2-induced hyperperfusion. Invest Ophthalmol Vis Sci (Suppl) 1996;37:265.

70.     Bhavani VD, Cantor LB, Hoop JC, Dobler AA, Sanders SP, Samuelson TW, Sponsel WE.  Phacoemulsification, intraocular lens implantation, and trabeculectomy, with or without mitomycin C.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:249.

71.     Ladd BS, Danis RP, Bingman DP, Yang Y, Sponsel WE.  Carbonic anhydrase histochemistry in kitten retinas with oxygen-induced retinopathy.  Invest Ophthalmol Vis Sci (Suppl) 1996;37:132.

71.     Sanders SP, Cantor LB, Dobler AA, Hoop JS, Sponsel WE.  Mitomycin C in complicated trabeculectomy:  A prospective comparison of 0.2 to 0.4 mg/cc.  Invest Ophthalmol Vis Sci  (Suppl) 1996;37:25.

73.     Azuara-Blanco A, Harris A, Cantor LB, Weinland M, Abreu M, Sponsel WE.  Effects of short-term increase of intraocular pressure in optic disc topography of normal eyes.  Invest Ophthalmol Vis Sci (Suppl) 1995;36:978.

74.     Gelvin JB, Malinovsky VE, Mickey D, Meets RE, Sponsel WE.  Determination of Heidelberg retinal tomographic stereometric parameters of normal and stages I, II, and III glaucomatous eyes.  Invest Ophthalmol Vis Sci (Suppl) 1995;36:976.

75.     Price ME, Jorgensen JH, Sponsel WE.  Growth characteristics of ocular pathogens in healon.  Invest Ophthalmol Vis Sci (Suppl) 1995;36:791.

76.     Haverly RF, Peters D, Taboada J, Sponsel WE, Bassi C, Mekelberg D, Stephen R.  Evaluating glaucoma using laser PERG.  Invest Ophthalmol Vis Sci (Suppl) 1995;36:333.

77.     Martin BJ, Harris A, Joos K, Beck D, Sponsel WE, Kay M.  Flow velocity and resistance index in the ophthalmic artery during experimental manipulation of the intraocular pressure. Invest Ophthalmol Vis Sci (Suppl) 1995;36:113.

78.     Gerber SL, Cantor LB, Sponsel WE.  A comparison of post‑operative complications utilizing the dual chamber double plate Molteno implant versus the standard double plate Molteno with suture ligation.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:781.

79.     Sanders SP, Cantor LB, Dobler AA, Hoop J, Sponsel WE, Shoemaker J.  Mitomycin C in complicated trabeculectomy:  a comparison of 0.2 and 0.4 mg cc.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:808.

80.     Nussmeier JM, Sponsel WE, Gelvin J.  National Society to Prevent Blindness and five affiliates.  NSPB national glaucoma screening study:  Phase III interim results.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:2792.

81.     Phillips CA, Cantor LB, Azuara-Blanco A, Harris A, Shoemaker J, Sponsel WE.  Effect of the different reference planes of the Heidelberg retinal tomograph on optic disc topographic analysis.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:415.

82.     Dobler AA, Cantor LB, Sanders SP, Hoop JS, Sponsel, WE.  Prospective comparative study of 0.2mg/ml Mitomycin C in primary glaucoma filtering surgery.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:807.

83.     Calvert R, Sponsel WE, Burgoyne JT, Shoemaker JA.  Comparable severity scales for Humphrey and Henson visual fields in glaucoma patients and suspects.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:4280.

84.     Burgoyne JT, Harris A, Shoemaker JA, Weinland M, Phillips C, Cantor LB, Sponsel WE.  Perimacular hemodynamic effects of betaxolol, carteolol, and levobunolol.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:626.

85.     Shoemaker JA, Harris A, Kutsbach P, Danis R, McNulty L, Martin BJ, Arend O, Sponsel WE, Wolf S.  Altered retinal vascular oxygen reactivity in early diabetic retinopathy as measured by scanning laser angiography.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:1581.

86.     Sponsel WE, Phillips C, Cantor LB, Eads S.  Sustained effects of beta blocker therapy on perimacular hemodynamics in normal eyes.  Invest Ophthalmol Vis Sci (Suppl) 1994;35:1872.

87.     Stein DL, Sponsel WE, Harris A, Wilson B, Mozeleski A.  The relationship of age and test reliability in multiple stimulus perimetry.  Invest Ophthalmol Vis Sci (Suppl) 1993;34:1262.

88.     Dobler AA, Cantor LB, Sondhi N, Ku S, Sponsel W.  Motility disturbances in double plate molteno implants.  Invest Ophthalmol Vis Sci (Suppl) 1993;34:732.

89.     Arend O, Harris A, Shoemaker JA, Sponsel WE, Knabben H, Reim M, Wolf S.  Perifoveal capillary microcirculation: Comparison of blue light simulation and scanning laser technique. Invest Ophthalmol Vis Sci (Suppl) 1993;34:1391.

90.     Mansberger S, Harris A, Arend O, Wolf S, Sponsel WE, Shoemaker J, Martin B.  Small PCO2 changes significantly alter retinal flow indices as measured by the scanning laser ophthalmoscope.  Invest Ophthalmol Vis Sci (Suppl) 1993;34:1395.

91.     Harris A, Arend O, Kopecky K, Caldmeyer K, Wolf S, Sponsel WE, Martin B.  Color Doppler and scanning laser ophthalmoscopic analysis of carotid, ophthalmic, and retinal arterial flow velocity in hypoxia and hyperoxia.  Invest Ophthalmol Vis Sci (Suppl) 1993;34:1129.

92.     Cantor LB, Arend, O, Harris A, Sponsel WE, Wolf S.  Measurement of superficial optic nerve head capillary flow velocities using scanning laser fluorescein angiography.  Invest Ophthalmol Vis Sci (Suppl) 1993;34:1285.

93.     Hoop J, Harris A, Shoemaker J, Sponsel WE, Cantor LB.  A comparison of global indices from the Humphrey 24‑2 Statpac and Fastpac programs in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (Suppl) 1993;34:1264.

94.     Stein D.L., Sponsel WE, Harris A, Wilson B, Mozeleski A.  The relationship of age and test reliability in multiple stimulus perimetry.  Invest Ophthalmol Vis Sci (Suppl) 1993;34:1262.

95.     Shoemaker JA, Vaught‑Godfrey R, Cantor LB, Harris A, Sponsel WE.  Drivers' peripheral vision: screening for visual field with the Optec 1000DMV.  Invest Ophthalmol Vis Sci (Suppl) 1993;34:895.

96.     Menage MJ, Robinson JC, Kaufman PL, Sponsel WE.  Retinal blood flow after superior cervical ganglionectomy: a laser Doppler velocimeter (LDV) study in the cynomolgus monkey.  Invest Ophthalmol Vis Sci (Suppl) 1992;33:812.

97.     Brady MA, Ritch R, Sponsel WE, Steinberger DA.  A comparison of perimetric screening methods in a normative population.  Invest Ophthalmol Vis Sci (Suppl) 1992;33:1389.

98.     Sponsel WE, Klein BEK, Klein R, Brady MA, Cantor LB, Martone J, Menage MJ, Nussmeier JM.  Analysis of visual field findings; Beaver Dam Eye Study.  Invest Ophthalmol Vis Sci (Suppl) 1992;33:1381.

99.     Shoemaker JA, Sponsel WE, Kaufman PL, Blum F, Brady MA, DePaul KL, Zetlan SR, Curran JA.  Correlation of the asymmetry of visual function and retinal leukocyte velocity in glaucoma; observed differences between timolol‑ and betaxolol‑treated patients.  Invest Ophthalmol Vis Sci (Suppl) 1992;33:1078.

100.   Starkey JT, Sponsel WE, Lin C, Menage MJ, Chioran GM.  Accuracy of the Keeler Pulsair 2000 non‑contact tonometer relative to Goldmann applanation in the IOP range 20‑55.  Invest Ophthalmol Vis Sci (Suppl) 1992;33:733.

101.   Sponsel WE, Brady MA, Zetlan SR, DePaul KL.  Comparison of Humphrey 30‑2 visual fields with those obtained using the Henson CFA3000, Marco MT‑336, and Dicon TKS 4000 multiple stimulus perimeters in normal and glaucomatous subjects.  Invest Ophthalmol Vis Sci (Suppl) 1991;32:1106.

102.   Zetlan SR, Sponsel WE.  Comparison of leukocyte velocity in normal and glaucomatous eyes during induced IOP increase.  Invest Ophthalmol Vis Sci (Suppl) 1991;32:1110.

103.   Sponsel WE, Brady MA, Zetlan SR, DePaul KL.  Correlation of Goldmann applanation and modified Pulsair non‑contact tonometer readings in normal human eyes during scleral suction induced changes in intraocular pressure.  Invest Ophthalmol Vis Sci (Suppl) 1990;31:14.

104.   Brady MA, Sponsel WE, DePaul KL, Kaufman PL.  Correlations of the asymmetry of visual function and retinal leukocyte velocity in treated glaucoma patients and untreated glaucoma suspects.  Invest Ophthalmol Vis Sci (Suppl) 1990;31:432.

105.   Martone JF, Sponsel WE, Brady MA, Wilson MR, Dailey JP, Mason RP, Kosoko O.  Visual field screening in a West Indian Black Population using Humphrey 30‑2 and Henson CFS2000 perimetry.  Invest Ophthalmol Vis Sci (Suppl) 1990;31:432.

106.   DePaul KL, Sponsel WE.  High‑speed multiple stimulus bowl perimetry using a four‑button, quadrant‑related patient response system.  Invest Ophthalmol Vis Sci (Suppl) 1990;31:15.

107.   Zetlan SR, Sponsel WE, Stodtmeister R.  Evaluation of normal and glaucomatous eyes using the VEP/pressure tolerance test and leukocyte flow analysis.  Invest Ophthalmol Vis Sci (Suppl) 1989;30:179.

108.   Martone JF, Shields MB, Sponsel WE, DePaul KL, Ollie AR, Stewart WC.  Correlation of subjective nonautomated visual field assessment and Vistech contrast sensitivity findings in glaucomatous, ocular hypertensive, and age‑related normal eyes.  Invest Ophthalmol Vis Sci (Suppl) 1989;30:178.

109.   DePaul KL, Sponsel WE.  The effects of carbon dioxide, oxygen, and mild hypoxia on retinal leukocyte flow.  Invest Ophthalmol Vis Sci (Suppl) 1989;30:137.

110.   Sponsel WE, DePaul KL, Kaufman PL.  Correlations of visual field, leukocyte velocity and IOP in glaucomatous and ocular hypertensive eyes.  Invest Ophthalmol Vis Sci (Suppl) 1989;30:56.

111.   Goeckner P, Sponsel W, Strinden T, DePaul K, Kaufman P.  A direct manometric comparison of the Keeler Pulsair with the Goldmann applanation tonometer in post‑mortem human eyes.  Invest Ophthalmol Vis Sci (Suppl) 1988;29:237.

112.   Sponsel W, Bowes H, Olander K, DePaul K, Kaufman P.  Clinical Evaluation of a new portable noncontact tonometer. Invest Ophthalmol Vis Sci (Suppl) 1988;29:42.

5.     Reviews and Editorials:

      *1.            Sponsel WE. Three cheers for DSEK (Descemet's stripping with endothelial keratoplasty)!

   Clin Experiment Ophthalmol. 2009 Dec;37(9):831-2.

*2.   Harisprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the

treatment of ofungal eye infections: a review of current literature. Br J Ophthalmol.   2008;92:871-8

*3.   Sponsel WE.  Integrating Numerical Indices of Structure and Function to

   Optimizee Diagnostic Sensitivity and Specificity in Screening for Glaucoma. 

                                      Ophthalmic Epidemiol. 2005 Jun;12(3):163-6.

          *4.           Sponsel WE.  Relationship between intraocular pressure and glaucomatous optic

                           neuropathy:  reply.  Clin Exp Ophthalmol 2003;31(2):168-171. (correspondence)

          *5.    Sponsel WE.  The trouble with tonometry.  Clin Exp Ophthalmol 2002;30(4):235-236.    

                           (editorial)

*6.    Sponsel WE.  Today’s clinical application of scanning laser technologies.  Int

         Ophthalmol 2001;23:207-208.

*7.    Sponsel WE, Gargasson W.  Foreward to special edition.  Lasers and Light in Ophthalmology, 1998;8.

*8.    Higginbotham EJ, Sponsel WE.  Diagnostic and therapeutic projections for glaucoma management into the 21st century:  psychophysiologic testing.  J Glaucoma 1993; 2:128-133. (review)

Exclusive Offer

COVID-19 UPDATE and your appointment please click here.

Dear Patient,
As a valued patient of the office of William E. Sponsel M.D., we appreciate the trust you place in us and want to inform you about how we are addressing the coronavirus (COVID-19) situation. We are closely monitoring events in our local community and continuously updating our policies and protocols as a result of new information.

Our highest priority is to keep all of our patients and staff as safe as possible. At the recommendation of CDC, we will be screening patients prior to allowing them to enter the facilities. If you have been exposed to anybody that has tested positive for COVID-19, or experiencing fever, cough, or flu-like symptoms please call to re-schedule your appointment.

Should you have an appointment you will be asked to call the office and stay in your vehicle/outside until our patient coordinator calls you to enter for your appointment. They will meet you at the suite, you will be required to fill out a questionnaire about any current medical symptoms so that we do not expose other patients and staff.

We will take your temperature upon entering, if you have a fever, cough, or experiencing any flu-like symptoms the urgency of your appointment will be reassessed by Dr. Sponsel to determine whether or not you will be seen at that time or re-scheduled. Please look for upcoming information regarding COVID-19, as the situation is changing daily.

If you have any questions or concerns about your appointment, please call our office at (210)223-9292, or after hours answering service at (757)-278-1657.
Thank you for your continued trust and loyalty as we work together to fight this virus.

Sincerely,
Dr. Sponsel M.D. and staff.

We accept most insurance plans!

Office Hours

DayMorningAfternoon
Monday9am2pm
Tuesday9am5:30pm
Wednesday9am6:00pm
Thursday9am6:00pm
Friday9am5:30pm
SaturdayClosedClosed
SundayClosedClosed
Day Morning Afternoon
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
9am 9am 9am 9am 9am Closed Closed
2pm 5:30pm 6:00pm 6:00pm 5:30pm Closed Closed